The Editorial Office has been made aware of potential issues surrounding the scientific validity of this paper, including identical image panels that appear across multiple publications. Figure panels 3C and 3D contains identical images with the following papers: ‘The Long Non-coding RNA LINC01705 Regulates the Development of Breast Cancer by Sponging miR-186-5p to Mediate TPR Expression as a Competitive Endogenous RNA’ (Figure panels 7C and 7D respectively; https://doi.org/10.3389/fgene.2020.00779), ‘Circular RNA circ-0016068 Promotes the Growth, Migration, and Invasion of Prostate Cancer Cells by Regulating the miR-330-3p/BMI-1 Axis as a Competing Endogenous RNA’ (Figure 2C and 2D respectively; https://doi.org/10.3389/fcell.2020.00827), and ‘LncRNA SNHG4 promotes osteosarcoma proliferation and migration by sponging miR‐377‐3p’ (Figure 2D; https://doi.org/10.1002%2Fmgg3.1349). Figure panels 3E and 3F share identical images with those of article ‘Long Non-Coding RNA ELFN1-AS1 Promoted Colon Cancer Cell Growth and Migration via the miR-191-5p/Special AT-Rich Sequence-Binding Protein 1 Axis’ Figure panel 3C (https://doi.org/10.3389%2Ffonc.2020.588360). The authors have been contacted with regards to these concerns.
Skip Nav Destination
Article navigation
June 2022
-
Cover Image
Cover Image
The cover of this issue of Bioscience Reports (volume 42, issue 6) features a crystal structure of G6PD compounded with Sorafenib. In their study, Wang et al. found that Sorafenib, the first-line treatment for hepatocellular carcinoma (HCC), had good sensitivity in HCC patients with high-G6PD.
Expression of Concern|
June 14 2022
Expression of Concern: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
Publisher: Portland Press Ltd
Online ISSN: 1573-4935
Print ISSN: 0144-8463
© 2022 The Author(s).
2022
This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
Biosci Rep (2022) 42 (6): BSR-2019-4026_EOC.
Connected Content
This is an Expression of Concern to:
Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
Citation
Expression of Concern: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma. Biosci Rep 30 June 2022; 42 (6): BSR–2019–4026_EOC. doi: https://doi.org/10.1042/BSR-2019-4026_EOC
Download citation file:
1,017
Views
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |